Higher-Throughput Processing of Proteoforms from Single Cells and Nuclei from Tumors via Arrayed Deposition

Abstract Single-cell proteomics (SCP) has transformed the study of cellular heterogeneity, yet intact proteoform-level analysis at single-cell resolution has remained technically constrained by throughput limitations and reliance on experiment-specific reference databases. Here, we present a series of integrated advances to single-cell proteoform imaging mass spectrometry (scPiMS) that substantially expand its throughput, analytical depth, and applicability to primary human tissue. Replacing stochastic dropcasting with image-guided cell arraying using the cellenONE platform increases productive cellograms from 1,400 to 5,500 per day. This reflects a four-fold improvement without compromising single-cell proteoform extraction quality. Through co-arraying of single cells and isolated nuclei from the same sample on one slide, we enable simultaneous profiling of cytoplasmic and nuclear proteoform compartments in one acquisition, with relative quantification. This recovers complementary proteoform landscapes that together increase the total coverage relative to either cellular fraction alone. A multistage database identification strategy combining abundance-scaled bottom-up databases, sample-specific top-down data, and a data-dependent score to filter SwissProt searches. This combinatorial approach prefilters ambiguous proteoforms to high-confidence hits for manual validation with ∼ 50% confirmation rates. Applied to freshly resected meningioma tissue from four patients spanning WHO grades 1 and 2, scPiMS identifies biologically coherent pathway signatures including amyloid and structural remodeling, receptor kinase oncogenic signaling, and epigenetic dysregulation. Together, these advances position scPiMS as a scalable platform to resolve proteoform-level biology in complex primary tissues with initial application to meningioma, revealing patient-specific enrichment of RAS/MAPK signaling components, epigenomic dysregulation, and receptor tyrosine kinase (RTK) signaling heterogeneity at single-cell and single-nucleus resolution.

Authors

Institutions

Publication Details

Journal
Analytical Chemistry
Published
2026-11-13
DOI
https://doi.org/10.1021/acs.analchem.6c05070
Primary Topic
Advanced Proteomics Techniques and Applications
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Higher-Throughput Processing of Proteoforms from Single Cells and Nuclei from Tumors via Arrayed Deposition

Kathleen McCortney, Craig Horbinski, Pei Su, Matthew C. Tate et al.
5 links
Analytical Chemistry
Advanced Proteomics Techniques and Applications
article

Higher-Throughput Processing of Proteoforms from Single Cells and Nuclei from Tumors via Arrayed Deposition

Kathleen McCortney, Craig Horbinski, Pei Su, Matthew C. Tate, Indira Plá, Claudia Ctortecka, Neil L. Kelleher, Jared O. Kafader, Michael A. R. Hollas, James P. Chandler, Hannah Zhou
article en

Abstract

Abstract Single-cell proteomics (SCP) has transformed the study of cellular heterogeneity, yet intact proteoform-level analysis at single-cell resolution has remained technically constrained by throughput limitations and reliance on experiment-specific reference databases. Here, we present a series of integrated advances to single-cell proteoform imaging mass spectrometry (scPiMS) that substantially expand its throughput, analytical depth, and applicability to primary human tissue. Replacing stochastic dropcasting with image-guided cell arraying using the cellenONE platform increases productive cellograms from 1,400 to 5,500 per day. This reflects a four-fold improvement without compromising single-cell proteoform extraction quality. Through co-arraying of single cells and isolated nuclei from the same sample on one slide, we enable simultaneous profiling of cytoplasmic and nuclear proteoform compartments in one acquisition, with relative quantification. This recovers complementary proteoform landscapes that together increase the total coverage relative to either cellular fraction alone. A multistage database identification strategy combining abundance-scaled bottom-up databases, sample-specific top-down data, and a data-dependent score to filter SwissProt searches. This combinatorial approach prefilters ambiguous proteoforms to high-confidence hits for manual validation with ∼ 50% confirmation rates. Applied to freshly resected meningioma tissue from four patients spanning WHO grades 1 and 2, scPiMS identifies biologically coherent pathway signatures including amyloid and structural remodeling, receptor kinase oncogenic signaling, and epigenetic dysregulation. Together, these advances position scPiMS as a scalable platform to resolve proteoform-level biology in complex primary tissues with initial application to meningioma, revealing patient-specific enrichment of RAS/MAPK signaling components, epigenomic dysregulation, and receptor tyrosine kinase (RTK) signaling heterogeneity at single-cell and single-nucleus resolution.

Analytical Chemistry
Northwestern University (US), Mayo Clinic (US), University of California System (US)
NIH Office of the Director, National Cancer Institute, National Institute of General Medical Sciences
Good health and well-being
Advanced Proteomics Techniques and Applications
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon